We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+12.91%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4.92B
AUM Growth
+$1.62B
(+49%)
Cap. Flow
+$1.41B
Cap. Flow
% of AUM
28.67%
Top 10 Holdings %
Top 10 Hldgs %
36.75%
Holding
1,419
New
468
Increased
176
Reduced
163
Closed
410
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$208M |
| 2 |
Amazon
AMZN
|
+$165M |
| 3 |
Advanced Micro Devices
AMD
|
+$86.9M |
| 4 |
XYZ
Block Inc
XYZ
|
+$33.2M |
| 5 |
Roku
ROKU
|
+$27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLRN
Acceleron Pharma
XLRN
|
+$10.3M |
| 2 |
Moderna
MRNA
|
+$9.79M |
| 3 |
JD.com
JD
|
+$6.14M |
| 4 |
AstraZeneca
AZN
|
+$5.27M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$4.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 8.5% |
| 2 | Technology | 4.33% |
| 3 | Communication Services | 2.49% |
| 4 | Healthcare | 1.87% |
| 5 | Financials | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
PUT
Kodiak Sciences
KOD
$2.5B
| $1.27M | 0.03% |
+15,000
| New | +$1.53M |
|
|
GGPI
427
CALL
DELISTED
Gores Guggenheim, Inc. Class A Common Stock
GGPI
| $1.27M | 0.03% |
+108,700
| New | +$1.25M |
|
428
Zillow
Z
$7.78B
| $1.25M | 0.03% |
+19,500
| New | +$1.41M |
|
429
CALL
Centene
CNC
$30.5B
| $1.24M | 0.03% |
15,100
-266,800
| -95% | -$19.5M |
|
430
CALL
Kinross Gold
KGC
$27.7B
| $1.24M | 0.03% |
+214,000
| New | +$1.28M |
|
431
CALL
Walker & Dunlop
WD
$1.73B
| $1.24M | 0.03% |
+8,200
| New | +$1.14M |
|
432
Pulmonx
LUNG
$52.8M
| $1.22M | 0.02% |
+38,000
| New | +$1.39M |
|
433
CALL
Kulicke & Soffa
KLIC
$4.34B
| $1.21M | 0.02% |
+20,000
| New | +$1.14M |
|
|
AYX
434
CALL
DELISTED
Alteryx Inc
AYX
| $1.21M | 0.02% |
20,000
-253,500
| -93% | -$17.5M |
|
435
CALL
Teva Pharmaceuticals
TEVA
$40.4B
| $1.2M | 0.02% |
150,200
+105,200
| +234% | +$950K |
|
436
PUT
Live Nation Entertainment
LYV
$42.9B
| $1.2M | 0.02% |
10,000
-31,000
| -76% | -$3.34M |
|
|
RXDX
437
CALL
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $1.19M | 0.02% |
+30,000
| New | +$939K |
|
438
Antero Resources
AR
$10.9B
| $1.18M | 0.02% |
67,500
-500
| -0.7% | -$9.47K |
|
439
Uber
UBER
$145B
| $1.17M | 0.02% |
28,000
-500
| -2% | -$21.6K |
|
|
440
Kinross Gold
KGC
$27.7B
| $1.16M | 0.02% |
200,000
+80,000
| +67% | +$478K |
|
|
441
PUT
Kinross Gold
KGC
$27.7B
| $1.16M | 0.02% |
200,000
| – | – |
|
442
Target
TGT
$66.3B
| $1.16M | 0.02% |
5,000
-9,000
| -64% | -$2.19M |
|
443
PUT
BridgeBio Pharma
BBIO
$16.4B
| $1.16M | 0.02% |
+69,300
| New | +$2.93M |
|
444
CALL
Goldman Sachs
GS
$289B
| $1.15M | 0.02% |
+3,000
| New | +$1.19M |
|
445
PUT
Qfin Holdings
QFIN
$1.68B
| $1.15M | 0.02% |
+50,000
| New | +$1.11M |
|
446
CALL
Lucid Motors
LCID
$3.11B
| $1.14M | 0.02% |
3,000
-3,800
| -56% | -$1.43M |
|
447
Williams-Sonoma
WSM
$27.5B
| $1.14M | 0.02% |
+13,464
| New | +$1.25M |
|
448
PUT
MP Materials
MP
$6.78B
| $1.14M | 0.02% |
+25,000
| New | +$985K |
|
449
CALL
Rayonier
RYN
$6.67B
| $1.13M | 0.02% |
30,862
-6,614
| -18% | -$230K |
|
|
TTM
450
PUT
DELISTED
Tata Motors Limited
TTM
| $1.12M | 0.02% |
35,000
| – | – |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q4 2021 Portfolio in Review
As of Q4 2021, SG3 Management held 1,419 positions worth $4.92B, up 49% from $3.3B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
SG3 Management deployed $1.41B of net new capital in Q4 2021, opening 468 new positions and adding to 176 existing holdings. Its largest new stake was Tesla: 619,500 shares worth $218M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 8.5% of assets, up from 0.74% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Moderna, an estimated $9.79M trimmed.
- SG3 Management's largest Q4 2021 buy was Tesla: 619,500 shares worth $218M.
- SG3 Management added most to Amazon in Q4 2021, an estimated $165M increase.
- SG3 Management's biggest Q4 2021 reduction was Moderna, cutting an estimated $9.79M.
- SG3 Management fully exited Acceleron Pharma in Q4 2021, selling an estimated $10.3M.
- SG3 Management's ten largest holdings make up 37% of its $4.92B portfolio in Q4 2021.
- SG3 Management opened 468 new positions and closed 410 in Q4 2021.
- SG3 Management's portfolio value rose 49% quarter-over-quarter to $4.92B.
Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.